Genomic Classifier ColoPrint Predicts Recurrence in Stage II Colorectal Cancer Patients More Accurately Than Clinical Factors

BACKGROUND. Approximately 20% of patients with stage II colorectal cancer will experience a relapse. Current clinical-pathologic stratification factors do not allow clear identification of these high-risk patients. ColoPrint (Agendia, Amsterdam, The Netherlands, http://www.agendia.com) is a gene exp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Kopetz, Scott, Tabernero, Josep, Rosenberg, Robert, Jiang, Zhi-Qin, Moreno, Víctor, Bachleitner-Hofmann, Thomas, Lanza, Giovanni, Stork-Sloots, Lisette, Maru, Dipen, Simon, Iris, Capellà, Gabriel, Salazar, Ramon
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2015
Assuntos:
Gastrointestinal Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4319631/
https://ncbi.nlm.nih.gov/pubmed/25561511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0325
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados